comparison of effectiveness of thiopental versus midazolam in patients with shoulder dislocation

comparison of effectiveness of thiopental versus midazolam in patients with shoulder dislocation who come to emergency department of Shariati and Imam Khomeini Hospitals

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201408068872N5

Enrollment

Registered

2014-08-23

Start date

2014-08-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shoulder dislocation. Dislocation of shoulder joint

Interventions

Intervention 1: In control group, patients receive midazolam (0.05-0.1 mg/kg) I.V. with fentanyl (1-2 microgr/kg) I.V. for sedation. Intervention 2: In intervention group, patients receive thiopantal

Treatment - Drugs

In control group, patients receive midazolam (0.05-0.1 mg/kg) I.V. with fentanyl (1-2 microgr/kg) I.V. for sedation.

In intervention group, patients receive thiopantal (1-2 mg/kg ) I.V. with fentanyl (1-2 microgr/kg) I.V. for sedation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criterias: All patients come come to Shariati and Imam Khomeini Hospitals with shoulder dislocatin during study period will enrolled to the study. Exclustion criterias: Severe nourovascular damages; coming after 24 hours; fracture dislocation; multiple trauma patient; unwilling to study participation; decreased level of conciousness; unstable vital signs; drugs sensitivity; ilicit drug abusers; age < 18; pregnant women; hepato renal disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Number of effort for reduction. Timepoint: after termination of reduction. Method of measurement: question from physician.;Muscle relaxation. Timepoint: after termination of reduction. Method of measurement: qualitave questionnaire.;Pain evaluation. Timepoint: before and just after reduction. Method of measurement: Neumeric Rating Scale.;Loss of conciousness time. Timepoint: one time after loss of responsiveness. Method of measurement: second, cornometer.;Time of arousal. Timepoint: time of full responsiveness. Method of measurement: second, cornometer.	—

Measure

Time frame

Number of effort for reduction. Timepoint: after termination of reduction. Method of measurement: question from physician.;Muscle relaxation. Timepoint: after termination of reduction. Method of measurement: qualitave questionnaire.;Pain evaluation. Timepoint: before and just after reduction. Method of measurement: Neumeric Rating Scale.;Loss of conciousness time. Timepoint: one time after loss of responsiveness. Method of measurement: second, cornometer.;Time of arousal. Timepoint: time of full responsiveness. Method of measurement: second, cornometer.

—

Secondary

Measure	Time frame
Patient satisfaction. Timepoint: After termination of Procedure. Method of measurement: Qualitative questionnare.;Physician satisfaction. Timepoint: After termination of Procedure. Method of measurement: Qualitative questionnare.;Complications. Timepoint: After termination of procidure. Method of measurement: questionnare(apnea, long decreased level of contiousness, nausea and vomiting, chest wall rigidity).	—

Measure

Time frame

Patient satisfaction. Timepoint: After termination of Procedure. Method of measurement: Qualitative questionnare.;Physician satisfaction. Timepoint: After termination of Procedure. Method of measurement: Qualitative questionnare.;Complications. Timepoint: After termination of procidure. Method of measurement: questionnare(apnea, long decreased level of contiousness, nausea and vomiting, chest wall rigidity).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Morteza Saeedi

Tehran University of Medical Sciences

m_saeedi@tums.ac.ir+98 21 8490 2719

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026